[144] Oncology Institute, Inc. SEC Filing

Rhea-AI Filing Summary

A shareholder filed a Form 144 notice to sell up to 50,000 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of $200,000. The shares relate to restricted stock acquired from the issuer in several grants between November 17, 2022 and June 14, 2024. The planned sale is listed for approximately November 18, 2025 on the NASDAQ, where about 98,381,340 shares of this class are outstanding. By signing the notice, the seller represents they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations and acknowledges that intentional misstatements can constitute a federal criminal violation.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	200000.00	98381340	11/18/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/17/2023	Restricted Stock	Issuer			1210	05/17/2023	Not Applicable
Common	06/14/2024	Restricted Stock	Issuer			46630	06/14/2024	Not Applicable
Common	11/17/2022	Restricted Stock	Issuer			2160	11/17/2022	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the TOI Form 144 filing disclose?

The Form 144 filing for TOI discloses a planned sale of up to 50,000 shares of common stock by a shareholder under Rule 144. The notice provides details on the number of shares, the broker, the approximate sale date, and the market where the shares may be sold.

How many TOI shares are planned to be sold under this Form 144?

The filing states that the shareholder intends to sell up to 50,000 shares of TOI common stock, with an indicated aggregate market value of $200,000.

Which broker will handle the TOI Form 144 share sale?

The notice lists Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza in New York, as the broker for the planned sale of TOI common stock.

On which exchange will the TOI shares be sold and when?

The Form 144 indicates that the TOI common shares are expected to be sold on the NASDAQ, with an approximate sale date of November 18, 2025, subject to market conditions and Rule 144 requirements.

How many TOI shares of this class are outstanding according to the filing?

The Form 144 lists 98,381,340 shares of the relevant class of TOI common stock as outstanding, providing context for the size of the planned 50,000-share sale.

How and when were the TOI shares in this Form 144 acquired?

The notice shows that the shares were acquired as restricted stock directly from the issuer on several dates, including November 17, 2022, May 17, 2023, and June 14, 2024, with payment described as not applicable.

What representation does the seller make in the TOI Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about TOI’s current or prospective operations that has not been publicly disclosed, and acknowledges that intentional misstatements or omissions can be federal criminal violations.